The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke

BACKGROUND: Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischaemic stroke within 3 hours of symptom onset. IST-3 seeks to determine whether a wider range of patients may benefit. DESIGN: International, multi-centre, prospective, randomize...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandercock, Peter, Lindley, Richard, Wardlaw, Joanna, Dennis, Martin, Lewis, Steff, Venables, Graham, Kobayashi, Adam, Czlonkowska, Anna, Berge, Eivind, Slot, Karsten Bruins, Murray, Veronica, Peeters, Andre, Hankey, Graeme, Matz, Karl, Brainin, Michael, Ricci, Stefano, Celani, Maria Grazia, Righetti, Enrico, Cantisani, Teresa, Gubitz, Gord, Phillips, Steve, Arauz, Antonio, Prasad, Kameshwar, Correia, Manuel, Lyrer, Phillippe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442584/
https://www.ncbi.nlm.nih.gov/pubmed/18559104
http://dx.doi.org/10.1186/1745-6215-9-37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442584/
https://www.ncbi.nlm.nih.gov/pubmed/18559104
http://dx.doi.org/10.1186/1745-6215-9-37

Ejemplares similares